Australia and New Zealand Prothrombin Complex Concentrate Market Size, Share & Covid-19 Impact Analysis, By Product (4-factor PCC and 3-factor PCC), By Application (Acquired Coagulation Factor Deficiency and Congenital Coagulation Factor Deficiency and By End User (Hospitals & Ambulatory Surgical Centers, Specialty Clinics, and Others), 2020-2027

Last Updated: February 24, 2025 | Format: PDF | Report ID: FBI104761

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2016-2027
Base Year	2019
Forecast Period	2020-2027
Historical Period	2016-2018
Unit	Value (USD million)
Segmentation	By Product Type 4-factor PCC 3-factor PCC
	By Application Acquired Congenital
	By End-User Hospitals & ASCs Specialty Clinics Others
	By Geography Australia and New Zealand